Prescription drug · ANDA
Megestrol Acetate NDC 51407-910
Megestrol acetate 40 mg/mL · Suspension · Oral · Golden State Medical Supply, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51407-910-24 | 51407091024 | 240 mL in 1 BOTTLE, PLASTIC (51407-910-24)Marketed from Apr 22, 2024 | |
| 51407-910-48 | 51407091048 | 480 mL in 1 BOTTLE, PLASTIC (51407-910-48)Marketed from Apr 22, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Megestrol Acetate
- Generic name (nonproprietary)
- megestrol acetate
- Active ingredients
- Megestrol acetate — 40 mg/mL
- Dosage form
- Suspension
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 075671
- Marketing start
- Listing expires
- Other FDA classes
- Progesterone Congeners (Chemical structure)
- Identifiers
- Product ID 51407-910_19c32f0a-07d6-26c2-e063-6294a90a49e4SPL ID 19c32f0a-07d6-26c2-e063-6294a90a49e4SPL set ID 19c33213-7919-208d-e063-6394a90a0f08RxCUI 860225UNII TJ2M0FR8ES
- Pharmacologic class
- Progestin
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451407091024followed by a unit qualifier and the quantityPackage 51407-0910-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Megestrol acetate oral suspension, USP is indicated for the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS).
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 075671
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Megestrol Acetate | Megestrol acetate 40 mg/mL | SuspensionOral | Precision Dose Inc. | 68094-174 |
| Megestrol Acetate | Megestrol acetate 40 mg/mL | SuspensionOral | Strides Pharma Science Limited | 64380-160 |
| Megestrol Acetate | Megestrol acetate 40 mg/mL | SuspensionOral | Natco Pharma USA LLC | 69339-160 |
| Megestrol Acetate | Megestrol acetate 400 mg/10mL | SuspensionOral | PAI Holdings, LLC dba PAI Pharma | 0121-0945 |
| Megestrol Acetate | Megestrol acetate 40 mg/mL | SuspensionOral | ATLANTIC BIOLOGICALS CORP. | 17856-0060 |
| Megestrol Acetate | Megestrol acetate 40 mg/mL | SuspensionOral | Precision Dose Inc. | 68094-063 |
| Megestrol Acetate | Megestrol acetate 40 mg/mL | SuspensionOral | Preferred Pharmaceuticals Inc. | 68788-8714 |
| Megestrol Acetate | Megestrol acetate 40 mg/mL | SuspensionOral | Kesin Pharma Corporation | 81033-150 |